Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.23 (Beat by $0.1) |
EPS GAAP Actual | $0.23 (Beat by $0.1) |
Revenue Actual | $0.175984B |
Revenue Surprise | Beat by $175.984M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.34 |
EPS GAAP Estimate | $0.34 |
Revenue Estimate | $0.1496285B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 1.545 | 22.89 | 1.46 | 1.63 | 2 |
Dec 2026 | 1.62 | 21.83 | 1.54 | 1.7 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.8 | 0.47 | 0.175984B | 29.21% | 30.53M |
FQ3 2024 (Sep 2024) | 0.09 | -1.44737 | 0.109408B | -14.36% | -163.04M |
FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 0.144309B | 16.09% | 144.31M |
FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 0.13786B | 18.94% | 137.86M |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 0.124583B | 0.75% | 124.58M |
FQ3 2023 (Sep 2023) | 0.29 | 0.29 | 0.125114B | 10.84% | 125.11M |
FQ2 2023 (Jun 2023) | 0.29 | 0.29 | 0.121087B | 2.36% | 121.09M |
FQ1 2023 (Mar 2023) | 0.34 | 0.34 | 0.111748B | 100% | 111.75M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.34
Consensus Revenue Estimates
0.1496285B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.39 | -- | 0.37983 | 0.39446 | 3 |
FQ3 2026 (Jul 2026) | 0.36 | -- | 0.35061 | 0.36412 | 3 |
FQ2 2026 (Jun 2026) | 0.36 | -- | 0.35038 | 0.3728 | 3 |
FQ1 2026 (Mar 2026) | 0.33 | -- | 0.32118 | 0.34174 | 3 |
FQ4 2025 (Oct 2025) | 0.36667 | -118.18 | 0.32202 | 0.38601 | 2 |
FQ3 2025 (Jul 2025) | 0.33667 | 73.27 | 0.29567 | 0.35443 | 2 |
FQ2 2025 (Jun 2025) | 0.34 | 8.82 | 0.33363 | 0.34864 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.16B | -- | 0.16B | 0.16B | 4 |
FQ3 2026 (Jul 2026) | 0.15B | -- | 0.15B | 0.16B | 4 |
FQ2 2026 (Jun 2026) | 0.15B | -- | 0.15B | 0.16B | 4 |
FQ1 2026 (Mar 2026) | 0.15B | -- | 0.15B | 0.15B | 4 |
FQ4 2025 (Oct 2025) | 0.15B | -15.71 | 0.14B | 0.16B | 1 |
FQ3 2025 (Jul 2025) | 0.15B | 26.4 | 0.13B | 0.15B | 1 |
FQ2 2025 (Jun 2025) | 0.15B | 3.56 | 0.15B | 0.15B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.33 | 0.8 | 0.47 | 58.75% |
FQ3 2024 (Sep 2024) | 1.53737 | 0.09 | -1.44737 | -1608.19% |
FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 100% | |
FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 100% | |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% | |
FQ3 2023 (Sep 2023) | 0.29 | 0.29 | 100% | |
FQ2 2023 (Jun 2023) | 0.29 | 0.29 | 100% | |
FQ1 2023 (Mar 2023) | 0.34 | 0.34 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.15B | $0.18B | $30.53M | 17.35% |
FQ3 2024 (Sep 2024) | $0.27B | $0.11B | $-163.04M | -149.02% |
FQ2 2024 (Jun 2024) | $0B | $0.14B | $144.31M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.14B | $137.86M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.12B | $124.58M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.13B | $125.11M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.12B | $121.09M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.11B | $111.75M | 100% |